

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of natural killer cell differentiation (GO:0032825) | 9.13538812 |
| 2 | regulation of granulocyte differentiation (GO:0030852) | 8.41271630 |
| 3 | * positive regulation of immunoglobulin production (GO:0002639) | 7.26460815 |
| 4 | positive regulation of interleukin-17 production (GO:0032740) | 7.17602995 |
| 5 | regulation of regulatory T cell differentiation (GO:0045589) | 7.02773222 |
| 6 | kinetochore assembly (GO:0051382) | 6.30593426 |
| 7 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 6.29802285 |
| 8 | regulation of natural killer cell differentiation (GO:0032823) | 6.18664555 |
| 9 | * positive regulation of B cell proliferation (GO:0030890) | 6.14345660 |
| 10 | * regulation of immunoglobulin production (GO:0002637) | 5.95533513 |
| 11 | positive regulation of organelle assembly (GO:1902117) | 5.92877947 |
| 12 | muscle organ morphogenesis (GO:0048644) | 5.83099824 |
| 13 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 5.71698140 |
| 14 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 5.68826255 |
| 15 | kinetochore organization (GO:0051383) | 5.61100528 |
| 16 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 5.40430455 |
| 17 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 5.30020940 |
| 18 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 5.25934394 |
| 19 | negative regulation of B cell proliferation (GO:0030889) | 5.19020115 |
| 20 | * positive regulation of production of molecular mediator of immune response (GO:0002702) | 4.88245906 |
| 21 | phospholipid scrambling (GO:0017121) | 4.84551287 |
| 22 | * positive regulation of B cell activation (GO:0050871) | 4.69549986 |
| 23 | positive regulation of natural killer cell activation (GO:0032816) | 4.55195920 |
| 24 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.38812338 |
| 25 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.38812338 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 4.38438060 |
| 27 | * regulation of chronic inflammatory response (GO:0002676) | 4.34010444 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.29062075 |
| 29 | * regulation of B cell proliferation (GO:0030888) | 4.24943209 |
| 30 | tolerance induction (GO:0002507) | 4.19663505 |
| 31 | response to inactivity (GO:0014854) | 4.18155548 |
| 32 | * regulation of MHC class II biosynthetic process (GO:0045346) | 4.16113833 |
| 33 | postsynaptic membrane organization (GO:0001941) | 4.10959430 |
| 34 | regulation of interleukin-17 production (GO:0032660) | 4.07137532 |
| 35 | * negative regulation of nitric oxide biosynthetic process (GO:0045019) | 4.07006808 |
| 36 | negative regulation of B cell activation (GO:0050869) | 4.05916493 |
| 37 | mucosal-associated lymphoid tissue development (GO:0048537) | 4.03367965 |
| 38 | Peyers patch development (GO:0048541) | 4.03367965 |
| 39 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 4.00734816 |
| 40 | termination of RNA polymerase I transcription (GO:0006363) | 4.00499159 |
| 41 | cellular response to interleukin-15 (GO:0071350) | 4.00281407 |
| 42 | chaperone-mediated protein transport (GO:0072321) | 3.93767906 |
| 43 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 3.93276517 |
| 44 | * regulation of production of molecular mediator of immune response (GO:0002700) | 3.92805704 |
| 45 | * CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.91806248 |
| 46 | * T-helper cell differentiation (GO:0042093) | 3.91806248 |
| 47 | platelet dense granule organization (GO:0060155) | 3.90561462 |
| 48 | * positive regulation of JAK-STAT cascade (GO:0046427) | 3.84826286 |
| 49 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 3.84253719 |
| 50 | negative regulation of B cell mediated immunity (GO:0002713) | 3.84253719 |
| 51 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 3.81026598 |
| 52 | * positive regulation of interleukin-10 production (GO:0032733) | 3.75312711 |
| 53 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71628362 |
| 54 | * regulation of B cell activation (GO:0050864) | 3.67377733 |
| 55 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.67315472 |
| 56 | mitochondrial RNA metabolic process (GO:0000959) | 3.62534946 |
| 57 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.61870424 |
| 58 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.61503218 |
| 59 | negative T cell selection (GO:0043383) | 3.57404024 |
| 60 | chemokine-mediated signaling pathway (GO:0070098) | 3.56330302 |
| 61 | cell wall macromolecule catabolic process (GO:0016998) | 3.54084562 |
| 62 | GTP biosynthetic process (GO:0006183) | 3.53006480 |
| 63 | positive regulation of humoral immune response (GO:0002922) | 3.52689108 |
| 64 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.48796910 |
| 65 | synaptic vesicle exocytosis (GO:0016079) | 3.45579952 |
| 66 | * alpha-beta T cell differentiation involved in immune response (GO:0002293) | 3.45199582 |
| 67 | * alpha-beta T cell activation involved in immune response (GO:0002287) | 3.45199582 |
| 68 | * T cell differentiation involved in immune response (GO:0002292) | 3.45199582 |
| 69 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.44694219 |
| 70 | vocalization behavior (GO:0071625) | 3.44588739 |
| 71 | imidazole-containing compound metabolic process (GO:0052803) | 3.42594640 |
| 72 | regulation of T cell tolerance induction (GO:0002664) | 3.39870233 |
| 73 | response to interleukin-15 (GO:0070672) | 3.39569358 |
| 74 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.38176044 |
| 75 | positive regulation of myeloid leukocyte differentiation (GO:0002763) | 3.36800146 |
| 76 | UTP biosynthetic process (GO:0006228) | 3.31344047 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.30373281 |
| 78 | regulation of synaptic vesicle transport (GO:1902803) | 3.29311076 |
| 79 | regulation of natural killer cell activation (GO:0032814) | 3.29304574 |
| 80 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.29046576 |
| 81 | removal of superoxide radicals (GO:0019430) | 3.28150978 |
| 82 | cellular response to superoxide (GO:0071451) | 3.28150978 |
| 83 | cellular response to oxygen radical (GO:0071450) | 3.28150978 |
| 84 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.27634415 |
| 85 | negative regulation of interleukin-12 production (GO:0032695) | 3.27414922 |
| 86 | negative regulation of cell killing (GO:0031342) | 3.26955392 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.26955392 |
| 88 | negative regulation of T cell differentiation in thymus (GO:0033085) | 3.23432770 |
| 89 | definitive hemopoiesis (GO:0060216) | 3.21774794 |
| 90 | regulation of inflammatory response to antigenic stimulus (GO:0002861) | 3.19114983 |
| 91 | * regulation of isotype switching to IgG isotypes (GO:0048302) | 3.18398942 |
| 92 | motile cilium assembly (GO:0044458) | 3.17178484 |
| 93 | natural killer cell differentiation (GO:0001779) | 3.16917808 |
| 94 | protein localization to synapse (GO:0035418) | 3.16665348 |
| 95 | glutamate secretion (GO:0014047) | 3.16447669 |
| 96 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.16044254 |
| 97 | positive regulation of cell killing (GO:0031343) | 3.15987660 |
| 98 | regulation of cell killing (GO:0031341) | 3.14508441 |
| 99 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14148558 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.13284742 |
| 101 | * regulation of lymphocyte mediated immunity (GO:0002706) | 3.13036316 |
| 102 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.12290406 |
| 103 | meiotic chromosome segregation (GO:0045132) | 3.11117505 |
| 104 | ribosome assembly (GO:0042255) | 3.10732603 |
| 105 | negative thymic T cell selection (GO:0045060) | 3.10281356 |
| 106 | * positive regulation of lymphocyte mediated immunity (GO:0002708) | 3.09714595 |
| 107 | negative regulation of neurotransmitter transport (GO:0051589) | 3.09330355 |
| 108 | presynaptic membrane assembly (GO:0097105) | 3.08263820 |
| 109 | * CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 3.07431552 |
| 110 | neuronal action potential propagation (GO:0019227) | 3.07326110 |
| 111 | negative regulation of type 2 immune response (GO:0002829) | 3.05927498 |
| 112 | T cell apoptotic process (GO:0070231) | 3.05711597 |
| 113 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.02638412 |
| 114 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.02638412 |
| 115 | purine-containing compound salvage (GO:0043101) | 3.00545990 |
| 116 | piRNA metabolic process (GO:0034587) | 3.00335770 |
| 117 | * positive regulation of leukocyte mediated immunity (GO:0002705) | 2.98481734 |
| 118 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96757779 |
| 119 | natural killer cell mediated immunity (GO:0002228) | 2.96695198 |
| 120 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.96695198 |
| 121 | presynaptic membrane organization (GO:0097090) | 2.96415905 |
| 122 | activation of protein kinase A activity (GO:0034199) | 2.95773137 |
| 123 | * regulation of isotype switching (GO:0045191) | 2.94911161 |
| 124 | response to cadmium ion (GO:0046686) | 2.93885869 |
| 125 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.92676286 |
| 126 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.90974676 |
| 127 | cell wall macromolecule metabolic process (GO:0044036) | 2.90320472 |
| 128 | positive regulation of neurotransmitter transport (GO:0051590) | 2.88942335 |
| 129 | UTP metabolic process (GO:0046051) | 2.87354488 |
| 130 | response to superoxide (GO:0000303) | 2.86798940 |
| 131 | * positive regulation of isotype switching (GO:0045830) | 2.86099589 |
| 132 | catecholamine transport (GO:0051937) | 2.84497934 |
| 133 | synaptic transmission, glutamatergic (GO:0035249) | 2.83945747 |
| 134 | fucose catabolic process (GO:0019317) | 2.83699397 |
| 135 | L-fucose metabolic process (GO:0042354) | 2.83699397 |
| 136 | L-fucose catabolic process (GO:0042355) | 2.83699397 |
| 137 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.83522071 |
| 138 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.81676234 |
| 139 | replication fork processing (GO:0031297) | 2.81377561 |
| 140 | DNA methylation involved in gamete generation (GO:0043046) | 2.80947431 |
| 141 | * negative regulation of adaptive immune response (GO:0002820) | 2.80474239 |
| 142 | * regulation of JAK-STAT cascade (GO:0046425) | 2.80054788 |
| 143 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.79887087 |
| 144 | * positive regulation of DNA recombination (GO:0045911) | 2.79652367 |
| 145 | regulation of tolerance induction (GO:0002643) | 2.78984141 |
| 146 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.78850424 |
| 147 | * positive regulation of immune effector process (GO:0002699) | 2.78696720 |
| 148 | catechol-containing compound biosynthetic process (GO:0009713) | 2.78578758 |
| 149 | catecholamine biosynthetic process (GO:0042423) | 2.78578758 |
| 150 | interferon-gamma production (GO:0032609) | 2.78437471 |
| 151 | * CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.77014975 |
| 152 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.75482378 |
| 153 | synaptic vesicle maturation (GO:0016188) | 2.74334540 |
| 154 | T cell receptor signaling pathway (GO:0050852) | 2.73072338 |
| 155 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.72932228 |
| 156 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.72274577 |
| 157 | T cell costimulation (GO:0031295) | 2.71585059 |
| 158 | * lymphocyte costimulation (GO:0031294) | 2.71585059 |
| 159 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.70456693 |
| 160 | positive regulation of granulocyte differentiation (GO:0030854) | 2.69476464 |
| 161 | regulation of defense response to virus by virus (GO:0050690) | 2.69168692 |
| 162 | glial cell proliferation (GO:0014009) | 2.68809863 |
| 163 | neuron-neuron synaptic transmission (GO:0007270) | 2.66462688 |
| 164 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.66259854 |
| 165 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.65504606 |
| 166 | cytoplasmic sequestering of transcription factor (GO:0042994) | 2.65469300 |
| 167 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 2.65048095 |
| 168 | secretory granule organization (GO:0033363) | 2.61925943 |
| 169 | neurotransmitter secretion (GO:0007269) | 2.60764995 |
| 170 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.59231483 |
| 171 | regulation of neurotransmitter secretion (GO:0046928) | 2.58928826 |
| 172 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.55442397 |
| 173 | negative regulation of blood circulation (GO:1903523) | 2.55401569 |
| 174 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.54207651 |
| 175 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 2.53994812 |
| 176 | * negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.52390302 |
| 177 | heparin metabolic process (GO:0030202) | 2.51633649 |
| 178 | heparin biosynthetic process (GO:0030210) | 2.51633649 |
| 179 | positive T cell selection (GO:0043368) | 2.49781421 |
| 180 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.49009985 |
| 181 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.48622035 |
| 182 | leukocyte aggregation (GO:0070486) | 2.47241394 |
| 183 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.45955292 |
| 184 | neurotransmitter uptake (GO:0001504) | 2.45441057 |
| 185 | startle response (GO:0001964) | 2.44951348 |
| 186 | dopamine transport (GO:0015872) | 2.44149940 |
| 187 | positive regulation of filopodium assembly (GO:0051491) | 2.42740158 |
| 188 | endosome to melanosome transport (GO:0035646) | 2.41983436 |
| 189 | endosome to pigment granule transport (GO:0043485) | 2.41983436 |
| 190 | signal peptide processing (GO:0006465) | 2.40024483 |
| 191 | negative regulation of T cell proliferation (GO:0042130) | 2.39850597 |
| 192 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.39457525 |
| 193 | regulation of podosome assembly (GO:0071801) | 14.9526465 |
| 194 | regulation of immunoglobulin secretion (GO:0051023) | 11.6420517 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 8.96981687 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.68969399 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.50680285 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.16081437 |
| 5 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.11429545 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.86655322 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.84575827 |
| 8 | TAF15_26573619_Chip-Seq_HEK293_Human | 3.49312756 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.46904893 |
| 10 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 3.05763444 |
| 11 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.05639411 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.98422349 |
| 13 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.90847801 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.52230744 |
| 15 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 2.45413109 |
| 16 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.42417333 |
| 17 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.38927231 |
| 18 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.31253854 |
| 19 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.28160214 |
| 20 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.28043404 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.12053006 |
| 22 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.09108637 |
| 23 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.06524600 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.06435222 |
| 25 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.99254539 |
| 26 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.98114752 |
| 27 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.92962542 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.92072648 |
| 29 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92004813 |
| 30 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.90876913 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.90621126 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.88597731 |
| 33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.86725400 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85807857 |
| 35 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.84746042 |
| 36 | * MYB_26560356_Chip-Seq_TH2_Human | 1.80795354 |
| 37 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.78671569 |
| 38 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76838684 |
| 39 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.74148585 |
| 40 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.67114048 |
| 41 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.66634122 |
| 42 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.62870976 |
| 43 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.62147947 |
| 44 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.61482855 |
| 45 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.61380585 |
| 46 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61105386 |
| 47 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58421089 |
| 48 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.58168238 |
| 49 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.56658200 |
| 50 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.56603891 |
| 51 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56370455 |
| 52 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.54036895 |
| 53 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53521093 |
| 54 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.52824536 |
| 55 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.52770511 |
| 56 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.52415232 |
| 57 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.51011614 |
| 58 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.50580746 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.49711836 |
| 60 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.49511363 |
| 61 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.49506013 |
| 62 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.48332603 |
| 63 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48100389 |
| 64 | FUS_26573619_Chip-Seq_HEK293_Human | 1.46282465 |
| 65 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.44292848 |
| 66 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.42889851 |
| 67 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.42889851 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41914673 |
| 69 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41339032 |
| 70 | GATA1_22025678_ChIP-Seq_K562_Human | 1.40693701 |
| 71 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.40242736 |
| 72 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.40222399 |
| 73 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.38100696 |
| 74 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.35359038 |
| 75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.34896824 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.34201672 |
| 77 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.33726409 |
| 78 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32858129 |
| 79 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31627697 |
| 80 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.27841856 |
| 81 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.26801697 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.23200586 |
| 83 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.22368093 |
| 84 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.20318631 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.19053332 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19030670 |
| 87 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18842269 |
| 88 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.17779680 |
| 89 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.17619945 |
| 90 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.16536802 |
| 91 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.16050096 |
| 92 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.15877708 |
| 93 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15866394 |
| 94 | EWS_26573619_Chip-Seq_HEK293_Human | 1.15347262 |
| 95 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14961344 |
| 96 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13080860 |
| 97 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.12848623 |
| 98 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12627173 |
| 99 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.11885043 |
| 100 | * FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.11780292 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11327074 |
| 102 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.10348833 |
| 103 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10325742 |
| 104 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09916232 |
| 105 | AR_25329375_ChIP-Seq_VCAP_Human | 1.09377939 |
| 106 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07372425 |
| 107 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.07117222 |
| 108 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06876784 |
| 109 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.05925186 |
| 110 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.05097176 |
| 111 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.05048849 |
| 112 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.04544920 |
| 113 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03016347 |
| 114 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.02964406 |
| 115 | GATA3_26560356_Chip-Seq_TH1_Human | 1.02385164 |
| 116 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.01778484 |
| 117 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.01120047 |
| 118 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00422468 |
| 119 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99783093 |
| 120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.99762753 |
| 121 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98431647 |
| 122 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98374941 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.97666648 |
| 124 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.97659335 |
| 125 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.97201463 |
| 126 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95978379 |
| 127 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.95845839 |
| 128 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.93956338 |
| 129 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93905168 |
| 130 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.92868643 |
| 131 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.92172437 |
| 132 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91681942 |
| 133 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.91658828 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.91642430 |
| 135 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.90986845 |
| 136 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90965425 |
| 137 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90440618 |
| 138 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.90151861 |
| 139 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.90124125 |
| 140 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.90077439 |
| 141 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89859720 |
| 142 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 0.88746416 |
| 143 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.87850536 |
| 144 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.87675804 |
| 145 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87586121 |
| 146 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.87027657 |
| 147 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.86904773 |
| 148 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.86551878 |
| 149 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.86548288 |
| 150 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86285418 |
| 151 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.84262016 |
| 152 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84110789 |
| 153 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.83580644 |
| 154 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81442478 |
| 155 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.81081109 |
| 156 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.79326312 |
| 157 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.79184760 |
| 158 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.79184760 |
| 159 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.78930393 |
| 160 | MYB_26560356_Chip-Seq_TH1_Human | 0.76730595 |
| 161 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.75714368 |
| 162 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.75690411 |
| 163 | RBPJ_21746931_ChIP-Seq_IB4_Human | 0.73862001 |
| 164 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.73426108 |
| 165 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.73314333 |
| 166 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.72632389 |
| 167 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.72282247 |
| 168 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.71803373 |
| 169 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.70341601 |
| 170 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.67996511 |
| 171 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.67996511 |
| 172 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.67841289 |
| 173 | MAF_26560356_Chip-Seq_TH2_Human | 0.67121396 |
| 174 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.67112747 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008875_abnormal_xenobiotic_pharmacok | 6.57401198 |
| 2 | MP0003718_maternal_effect | 3.85435040 |
| 3 | MP0003880_abnormal_central_pattern | 3.59593755 |
| 4 | MP0005671_abnormal_response_to | 3.43819606 |
| 5 | MP0004742_abnormal_vestibular_system | 3.36844258 |
| 6 | MP0003303_peritoneal_inflammation | 3.17701315 |
| 7 | MP0004859_abnormal_synaptic_plasticity | 3.01483925 |
| 8 | MP0004510_myositis | 2.99079136 |
| 9 | MP0002332_abnormal_exercise_endurance | 2.90879042 |
| 10 | MP0002009_preneoplasia | 2.80859163 |
| 11 | MP0001188_hyperpigmentation | 2.79641922 |
| 12 | MP0002138_abnormal_hepatobiliary_system | 2.65684743 |
| 13 | MP0003635_abnormal_synaptic_transmissio | 2.56788352 |
| 14 | MP0009333_abnormal_splenocyte_physiolog | 2.53482086 |
| 15 | MP0009745_abnormal_behavioral_response | 2.49010257 |
| 16 | MP0009840_abnormal_foam_cell | 2.47685030 |
| 17 | MP0002733_abnormal_thermal_nociception | 2.45293750 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.43301955 |
| 19 | * MP0005310_abnormal_salivary_gland | 2.40631691 |
| 20 | MP0001968_abnormal_touch/_nociception | 2.39209591 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.36574961 |
| 22 | MP0001853_heart_inflammation | 2.33032295 |
| 23 | MP0002166_altered_tumor_susceptibility | 2.31422442 |
| 24 | MP0003763_abnormal_thymus_physiology | 2.24006028 |
| 25 | MP0004381_abnormal_hair_follicle | 2.18958936 |
| 26 | MP0009046_muscle_twitch | 2.18150040 |
| 27 | MP0002064_seizures | 2.18022271 |
| 28 | MP0003436_decreased_susceptibility_to | 2.14651390 |
| 29 | MP0003646_muscle_fatigue | 2.13983628 |
| 30 | MP0008877_abnormal_DNA_methylation | 2.11808140 |
| 31 | MP0001970_abnormal_pain_threshold | 2.08072566 |
| 32 | MP0002006_tumorigenesis | 2.04522997 |
| 33 | MP0002736_abnormal_nociception_after | 2.04222868 |
| 34 | MP0002572_abnormal_emotion/affect_behav | 1.96724949 |
| 35 | MP0004270_analgesia | 1.93568929 |
| 36 | MP0006276_abnormal_autonomic_nervous | 1.91858230 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.90477734 |
| 38 | MP0003300_gastrointestinal_ulcer | 1.89212356 |
| 39 | MP0002272_abnormal_nervous_system | 1.88159533 |
| 40 | MP0008058_abnormal_DNA_repair | 1.86645931 |
| 41 | MP0001502_abnormal_circadian_rhythm | 1.85613596 |
| 42 | MP0005451_abnormal_body_composition | 1.84396211 |
| 43 | MP0002734_abnormal_mechanical_nocicepti | 1.83301985 |
| 44 | MP0008057_abnormal_DNA_replication | 1.78228529 |
| 45 | MP0009785_altered_susceptibility_to | 1.65888745 |
| 46 | * MP0001873_stomach_inflammation | 1.64776951 |
| 47 | MP0001486_abnormal_startle_reflex | 1.64533496 |
| 48 | MP0001984_abnormal_olfaction | 1.52828302 |
| 49 | MP0002638_abnormal_pupillary_reflex | 1.52510114 |
| 50 | MP0003724_increased_susceptibility_to | 1.51370943 |
| 51 | MP0008569_lethality_at_weaning | 1.51201306 |
| 52 | * MP0001835_abnormal_antigen_presentation | 1.50261851 |
| 53 | MP0001905_abnormal_dopamine_level | 1.46735640 |
| 54 | MP0003045_fibrosis | 1.46641108 |
| 55 | MP0005645_abnormal_hypothalamus_physiol | 1.44573646 |
| 56 | MP0003787_abnormal_imprinting | 1.43653257 |
| 57 | MP0000465_gastrointestinal_hemorrhage | 1.43510573 |
| 58 | MP0005395_other_phenotype | 1.42747075 |
| 59 | MP0002067_abnormal_sensory_capabilities | 1.41447167 |
| 60 | MP0004145_abnormal_muscle_electrophysio | 1.35475294 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.33798061 |
| 62 | * MP0001800_abnormal_humoral_immune | 1.32804565 |
| 63 | MP0004142_abnormal_muscle_tone | 1.32749001 |
| 64 | MP0004811_abnormal_neuron_physiology | 1.31195860 |
| 65 | MP0002822_catalepsy | 1.30492835 |
| 66 | * MP0005000_abnormal_immune_tolerance | 1.30318224 |
| 67 | MP0005423_abnormal_somatic_nervous | 1.30017151 |
| 68 | MP0008789_abnormal_olfactory_epithelium | 1.29675124 |
| 69 | MP0000569_abnormal_digit_pigmentation | 1.28986324 |
| 70 | MP0002277_abnormal_respiratory_mucosa | 1.28797679 |
| 71 | MP0001529_abnormal_vocalization | 1.28253895 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.24892973 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.24134721 |
| 74 | * MP0008469_abnormal_protein_level | 1.23617431 |
| 75 | MP0001881_abnormal_mammary_gland | 1.23557423 |
| 76 | * MP0002723_abnormal_immune_serum | 1.18523290 |
| 77 | * MP0005387_immune_system_phenotype | 1.17779748 |
| 78 | * MP0001790_abnormal_immune_system | 1.17779748 |
| 79 | MP0005386_behavior/neurological_phenoty | 1.17233647 |
| 80 | MP0004924_abnormal_behavior | 1.17233647 |
| 81 | MP0000372_irregular_coat_pigmentation | 1.16495367 |
| 82 | MP0003186_abnormal_redox_activity | 1.16098585 |
| 83 | MP0002184_abnormal_innervation | 1.14676279 |
| 84 | * MP0005025_abnormal_response_to | 1.13634943 |
| 85 | MP0003866_abnormal_defecation | 1.13178128 |
| 86 | * MP0002429_abnormal_blood_cell | 1.13004909 |
| 87 | MP0004147_increased_porphyrin_level | 1.12134850 |
| 88 | MP0005408_hypopigmentation | 1.12104516 |
| 89 | * MP0002398_abnormal_bone_marrow | 1.11957037 |
| 90 | MP0002102_abnormal_ear_morphology | 1.11486516 |
| 91 | * MP0001819_abnormal_immune_cell | 1.10041079 |
| 92 | * MP0002420_abnormal_adaptive_immunity | 1.09765938 |
| 93 | MP0008874_decreased_physiological_sensi | 1.09627948 |
| 94 | MP0001440_abnormal_grooming_behavior | 1.09507114 |
| 95 | MP0003699_abnormal_female_reproductive | 1.09178245 |
| 96 | MP0003075_altered_response_to | 1.09008979 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 1.08832262 |
| 98 | MP0009697_abnormal_copulation | 1.07802360 |
| 99 | MP0001765_abnormal_ion_homeostasis | 1.05469417 |
| 100 | MP0002210_abnormal_sex_determination | 1.04914276 |
| 101 | MP0005535_abnormal_body_temperature | 1.03995050 |
| 102 | MP0002933_joint_inflammation | 1.03181073 |
| 103 | MP0005448_abnormal_energy_balance | 1.02484566 |
| 104 | MP0002557_abnormal_social/conspecific_i | 1.01907408 |
| 105 | MP0010155_abnormal_intestine_physiology | 0.99195853 |
| 106 | MP0003122_maternal_imprinting | 0.98876072 |
| 107 | * MP0002452_abnormal_antigen_presenting | 0.98317216 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.96535537 |
| 109 | MP0004484_altered_response_of | 0.94043369 |
| 110 | MP0002095_abnormal_skin_pigmentation | 0.93682278 |
| 111 | MP0005085_abnormal_gallbladder_physiolo | 0.92968569 |
| 112 | MP0000427_abnormal_hair_cycle | 0.92861096 |
| 113 | MP0000778_abnormal_nervous_system | 0.91435999 |
| 114 | MP0005409_darkened_coat_color | 0.90780402 |
| 115 | * MP0000716_abnormal_immune_system | 0.89702653 |
| 116 | * MP0001663_abnormal_digestive_system | 0.89585905 |
| 117 | MP0004084_abnormal_cardiac_muscle | 0.89469747 |
| 118 | MP0005165_increased_susceptibility_to | 0.88069934 |
| 119 | MP0003191_abnormal_cellular_cholesterol | 0.87452052 |
| 120 | * MP0008872_abnormal_physiological_respon | 0.87381174 |
| 121 | MP0003633_abnormal_nervous_system | 0.85869244 |
| 122 | MP0003252_abnormal_bile_duct | 0.85552712 |
| 123 | MP0005360_urolithiasis | 0.85224089 |
| 124 | MP0000685_abnormal_immune_system | 0.84751646 |
| 125 | MP0002234_abnormal_pharynx_morphology | 0.84616262 |
| 126 | MP0001919_abnormal_reproductive_system | 0.84403992 |
| 127 | MP0003879_abnormal_hair_cell | 0.83504337 |
| 128 | MP0002066_abnormal_motor_capabilities/c | 0.83104332 |
| 129 | MP0005499_abnormal_olfactory_system | 0.82286074 |
| 130 | MP0005394_taste/olfaction_phenotype | 0.82286074 |
| 131 | MP0005410_abnormal_fertilization | 0.82282605 |
| 132 | MP0002405_respiratory_system_inflammati | 0.82055333 |
| 133 | MP0003943_abnormal_hepatobiliary_system | 0.80013226 |
| 134 | MP0005075_abnormal_melanosome_morpholog | 0.79730864 |
| 135 | MP0000703_abnormal_thymus_morphology | 0.79470031 |
| 136 | MP0001243_abnormal_dermal_layer | 0.79013430 |
| 137 | MP0002882_abnormal_neuron_morphology | 0.78518938 |
| 138 | MP0002909_abnormal_adrenal_gland | 0.78197042 |
| 139 | MP0005389_reproductive_system_phenotype | 0.77335961 |
| 140 | MP0002163_abnormal_gland_morphology | 0.76506283 |
| 141 | MP0002722_abnormal_immune_system | 0.75830547 |
| 142 | MP0003567_abnormal_fetal_cardiomyocyte | 0.74643629 |
| 143 | MP0004808_abnormal_hematopoietic_stem | 0.74616244 |
| 144 | * MP0000477_abnormal_intestine_morphology | 0.74142785 |
| 145 | MP0005167_abnormal_blood-brain_barrier | 0.73833296 |
| 146 | MP0009765_abnormal_xenobiotic_induced | 0.72490039 |
| 147 | MP0000689_abnormal_spleen_morphology | 0.72427406 |
| 148 | MP0004947_skin_inflammation | 0.72384510 |
| 149 | MP0003950_abnormal_plasma_membrane | 0.72087222 |
| 150 | * MP0001845_abnormal_inflammatory_respons | 0.71949744 |
| 151 | MP0003221_abnormal_cardiomyocyte_apopto | 0.71646878 |
| 152 | MP0005636_abnormal_mineral_homeostasis | 0.70282908 |
| 153 | * MP0002419_abnormal_innate_immunity | 0.67835063 |
| 154 | MP0006072_abnormal_retinal_apoptosis | 0.66332698 |
| 155 | MP0001929_abnormal_gametogenesis | 0.64239930 |
| 156 | MP0002139_abnormal_hepatobiliary_system | 0.63894164 |
| 157 | MP0002019_abnormal_tumor_incidence | 0.63452915 |
| 158 | MP0008873_increased_physiological_sensi | 0.61251877 |
| 159 | MP0003136_yellow_coat_color | 0.61126763 |
| 160 | MP0000627_abnormal_mammary_gland | 0.59753758 |
| 161 | MP0003077_abnormal_cell_cycle | 0.59528828 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic diarrhea (HP:0002028) | 6.85663782 |
| 2 | Retrobulbar optic neuritis (HP:0100654) | 6.35081492 |
| 3 | Optic neuritis (HP:0100653) | 6.35081492 |
| 4 | Large for gestational age (HP:0001520) | 5.78762853 |
| 5 | Orchitis (HP:0100796) | 5.29321915 |
| 6 | Myositis (HP:0100614) | 4.68332291 |
| 7 | Scanning speech (HP:0002168) | 4.27159840 |
| 8 | Abnormality of the prostate (HP:0008775) | 4.26597438 |
| 9 | Fibular aplasia (HP:0002990) | 4.20537891 |
| 10 | Focal motor seizures (HP:0011153) | 4.18843690 |
| 11 | Febrile seizures (HP:0002373) | 4.12318814 |
| 12 | Exertional dyspnea (HP:0002875) | 4.09732574 |
| 13 | Absent/shortened dynein arms (HP:0200106) | 4.07946500 |
| 14 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 4.07946500 |
| 15 | Aplasia/Hypoplasia of the ulna (HP:0006495) | 4.07011537 |
| 16 | Keratoconjunctivitis sicca (HP:0001097) | 3.91444119 |
| 17 | Pulmonary infiltrates (HP:0002113) | 3.89942415 |
| 18 | Gangrene (HP:0100758) | 3.87354218 |
| 19 | Abnormal pupillary function (HP:0007686) | 3.84437945 |
| 20 | Hypoplasia of the ulna (HP:0003022) | 3.80593569 |
| 21 | Keratoconjunctivitis (HP:0001096) | 3.64246959 |
| 22 | Aplastic anemia (HP:0001915) | 3.61637930 |
| 23 | Pulmonary embolism (HP:0002204) | 3.53222452 |
| 24 | Arterial thrombosis (HP:0004420) | 3.51487563 |
| 25 | Limb hypertonia (HP:0002509) | 3.46823767 |
| 26 | Increased hepatocellular lipid droplets (HP:0006565) | 3.43378810 |
| 27 | Hemoptysis (HP:0002105) | 3.36586220 |
| 28 | B lymphocytopenia (HP:0010976) | 3.31440587 |
| 29 | Abnormality of B cell number (HP:0010975) | 3.31440587 |
| 30 | Short tibia (HP:0005736) | 3.28763723 |
| 31 | Inflammation of the large intestine (HP:0002037) | 3.23845966 |
| 32 | Cerebral hemorrhage (HP:0001342) | 3.18325030 |
| 33 | Epileptic encephalopathy (HP:0200134) | 3.16935384 |
| 34 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.15953494 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 3.14345154 |
| 36 | Obstructive lung disease (HP:0006536) | 3.13364169 |
| 37 | Chronic obstructive pulmonary disease (HP:0006510) | 3.13364169 |
| 38 | Abnormality of binocular vision (HP:0011514) | 3.10873385 |
| 39 | Diplopia (HP:0000651) | 3.10873385 |
| 40 | Renal Fanconi syndrome (HP:0001994) | 3.08793596 |
| 41 | Chest pain (HP:0100749) | 3.07849099 |
| 42 | Vasculitis (HP:0002633) | 3.02779724 |
| 43 | T lymphocytopenia (HP:0005403) | 3.00653425 |
| 44 | Hypothermia (HP:0002045) | 3.00637912 |
| 45 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.97993435 |
| 46 | Respiratory difficulties (HP:0002880) | 2.93548293 |
| 47 | Nasal polyposis (HP:0100582) | 2.93450256 |
| 48 | Adactyly (HP:0009776) | 2.92347507 |
| 49 | Deep philtrum (HP:0002002) | 2.91588375 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.91514862 |
| 51 | Colon cancer (HP:0003003) | 2.91509562 |
| 52 | Atonic seizures (HP:0010819) | 2.90190276 |
| 53 | Epistaxis (HP:0000421) | 2.79025344 |
| 54 | Abnormality of T cell number (HP:0011839) | 2.78545404 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.73675490 |
| 56 | Forearm undergrowth (HP:0009821) | 2.72611192 |
| 57 | IgM deficiency (HP:0002850) | 2.71850534 |
| 58 | Glomerulopathy (HP:0100820) | 2.70282237 |
| 59 | Progressive muscle weakness (HP:0003323) | 2.68803648 |
| 60 | Pendular nystagmus (HP:0012043) | 2.68265651 |
| 61 | Ureteral stenosis (HP:0000071) | 2.67567459 |
| 62 | Progressive cerebellar ataxia (HP:0002073) | 2.66665863 |
| 63 | Abnormal hair whorl (HP:0010721) | 2.65479945 |
| 64 | Thrombophlebitis (HP:0004418) | 2.63670463 |
| 65 | Myokymia (HP:0002411) | 2.61053613 |
| 66 | Paralysis (HP:0003470) | 2.60614328 |
| 67 | Polyneuropathy (HP:0001271) | 2.59165267 |
| 68 | Radial bowing (HP:0002986) | 2.58472025 |
| 69 | Postural instability (HP:0002172) | 2.57540587 |
| 70 | Primitive neuroectodermal tumor (HP:0030065) | 2.57415111 |
| 71 | Neuroblastic tumors (HP:0004376) | 2.57415111 |
| 72 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 2.57415111 |
| 73 | Neuroblastoma (HP:0003006) | 2.57415111 |
| 74 | Neuroendocrine neoplasm (HP:0100634) | 2.52121226 |
| 75 | Severe combined immunodeficiency (HP:0004430) | 2.51815688 |
| 76 | Spinal cord compression (HP:0002176) | 2.50861201 |
| 77 | Hyperventilation (HP:0002883) | 2.49907792 |
| 78 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.49789071 |
| 79 | Progressive inability to walk (HP:0002505) | 2.49652410 |
| 80 | Focal seizures (HP:0007359) | 2.49468109 |
| 81 | Male infertility (HP:0003251) | 2.47765556 |
| 82 | Gaze-evoked nystagmus (HP:0000640) | 2.45817310 |
| 83 | Meningitis (HP:0001287) | 2.41934308 |
| 84 | Abnormality of the nasal mucosa (HP:0000433) | 2.41806258 |
| 85 | Megalencephaly (HP:0001355) | 2.41574006 |
| 86 | Humeroradial synostosis (HP:0003041) | 2.40009972 |
| 87 | Synostosis involving the elbow (HP:0003938) | 2.40009972 |
| 88 | Ureteral obstruction (HP:0006000) | 2.39703160 |
| 89 | Ragged-red muscle fibers (HP:0003200) | 2.37436386 |
| 90 | Paresthesia (HP:0003401) | 2.34299014 |
| 91 | Thyroiditis (HP:0100646) | 2.33253827 |
| 92 | Visual hallucinations (HP:0002367) | 2.32592876 |
| 93 | Abnormal ciliary motility (HP:0012262) | 2.30857698 |
| 94 | Abnormality of T cells (HP:0002843) | 2.29871822 |
| 95 | Ependymoma (HP:0002888) | 2.29805107 |
| 96 | Amaurosis fugax (HP:0100576) | 2.28777794 |
| 97 | Delayed CNS myelination (HP:0002188) | 2.28188379 |
| 98 | Type 2 muscle fiber atrophy (HP:0003554) | 2.27882962 |
| 99 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.27207820 |
| 100 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.27207820 |
| 101 | Abnormality of the pericardium (HP:0001697) | 2.25800019 |
| 102 | 3-Methylglutaconic aciduria (HP:0003535) | 2.25464264 |
| 103 | Acute necrotizing encephalopathy (HP:0006965) | 2.24940376 |
| 104 | Medial flaring of the eyebrow (HP:0010747) | 2.23684397 |
| 105 | Poor eye contact (HP:0000817) | 2.20642934 |
| 106 | Urticaria (HP:0001025) | 2.20559792 |
| 107 | Stomatitis (HP:0010280) | 2.20307129 |
| 108 | Pheochromocytoma (HP:0002666) | 2.19487862 |
| 109 | Thrombocytosis (HP:0001894) | 2.18059743 |
| 110 | Gastrointestinal infarctions (HP:0005244) | 2.18004725 |
| 111 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.16976713 |
| 112 | Abnormality of male internal genitalia (HP:0000022) | 2.16709539 |
| 113 | Truncal ataxia (HP:0002078) | 2.16288175 |
| 114 | Abnormality of the pleura (HP:0002103) | 2.15863008 |
| 115 | Encephalitis (HP:0002383) | 2.15154712 |
| 116 | Menstrual irregularities (HP:0000858) | 2.13215085 |
| 117 | Oral leukoplakia (HP:0002745) | 2.12782140 |
| 118 | Somatic mutation (HP:0001428) | 2.12283829 |
| 119 | Progressive microcephaly (HP:0000253) | 2.11902897 |
| 120 | Cavernous hemangioma (HP:0001048) | 2.08782844 |
| 121 | Carpal synostosis (HP:0009702) | 2.07483283 |
| 122 | Increased CSF lactate (HP:0002490) | 2.06719566 |
| 123 | Vertigo (HP:0002321) | 2.06449698 |
| 124 | Pulmonary fibrosis (HP:0002206) | 2.05957663 |
| 125 | Impaired platelet aggregation (HP:0003540) | 2.05424322 |
| 126 | Abnormal platelet function (HP:0011869) | 2.05424322 |
| 127 | Increased intramyocellular lipid droplets (HP:0012240) | 2.05206532 |
| 128 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.04519923 |
| 129 | IgG deficiency (HP:0004315) | 2.04489261 |
| 130 | Muscle fiber atrophy (HP:0100295) | 2.03105359 |
| 131 | Increased serum lactate (HP:0002151) | 2.03037430 |
| 132 | Limb dystonia (HP:0002451) | 2.02846354 |
| 133 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.01551400 |
| 134 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.01344829 |
| 135 | Short 1st metacarpal (HP:0010034) | 2.00734202 |
| 136 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.00734202 |
| 137 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.97885612 |
| 138 | Enlarged epiphyses (HP:0010580) | 1.97655070 |
| 139 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.96933063 |
| 140 | Poor suck (HP:0002033) | 1.96105269 |
| 141 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.94596162 |
| 142 | Abnormality of abdominal situs (HP:0011620) | 1.94291947 |
| 143 | Abdominal situs inversus (HP:0003363) | 1.94291947 |
| 144 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.93290334 |
| 145 | Supernumerary spleens (HP:0009799) | 1.92781211 |
| 146 | Abnormality of eosinophils (HP:0001879) | 1.92079121 |
| 147 | Genetic anticipation (HP:0003743) | 1.91287519 |
| 148 | Inability to walk (HP:0002540) | 1.89191177 |
| 149 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88942814 |
| 150 | Autoimmune hemolytic anemia (HP:0001890) | 1.88749557 |
| 151 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.88509025 |
| 152 | Hypercalciuria (HP:0002150) | 1.87555794 |
| 153 | Generalized tonic-clonic seizures (HP:0002069) | 1.86336206 |
| 154 | Fatigue (HP:0012378) | 1.85493123 |
| 155 | Stillbirth (HP:0003826) | 1.84839110 |
| 156 | Decreased central vision (HP:0007663) | 1.84552660 |
| 157 | Keratitis (HP:0000491) | 1.84491453 |
| 158 | Abnormal social behavior (HP:0012433) | 1.84399350 |
| 159 | Impaired social interactions (HP:0000735) | 1.84399350 |
| 160 | Specific learning disability (HP:0001328) | 1.83939057 |
| 161 | Protruding tongue (HP:0010808) | 1.83859081 |
| 162 | Polyphagia (HP:0002591) | 1.83522122 |
| 163 | Anxiety (HP:0000739) | 1.82957174 |
| 164 | Gait imbalance (HP:0002141) | 1.82948976 |
| 165 | Increased muscle lipid content (HP:0009058) | 1.81245935 |
| 166 | Combined immunodeficiency (HP:0005387) | 1.80873869 |
| 167 | Progressive macrocephaly (HP:0004481) | 1.80834553 |
| 168 | Acute encephalopathy (HP:0006846) | 1.80780031 |
| 169 | Mutism (HP:0002300) | 1.80323142 |
| 170 | Gastrointestinal stroma tumor (HP:0100723) | 1.80208811 |
| 171 | Agitation (HP:0000713) | 1.80139716 |
| 172 | Nonprogressive disorder (HP:0003680) | 1.79972112 |
| 173 | Synostosis involving bones of the hand (HP:0004278) | 1.79490740 |
| 174 | Recurrent bronchitis (HP:0002837) | 1.78753363 |
| 175 | Congenital sensorineural hearing impairment (HP:0008527) | 1.77451682 |
| 176 | Abnormality of the 1st metacarpal (HP:0010009) | 1.76694659 |
| 177 | Cerebral ischemia (HP:0002637) | 1.76565191 |
| 178 | Abnormal biliary tract physiology (HP:0012439) | 1.76366934 |
| 179 | Bile duct proliferation (HP:0001408) | 1.76366934 |
| 180 | 2-3 toe syndactyly (HP:0004691) | 1.76096293 |
| 181 | Exercise intolerance (HP:0003546) | 1.75622740 |
| 182 | Nervous tissue neoplasm (HP:0030060) | 1.74997016 |
| 183 | Neuroectodermal neoplasm (HP:0030061) | 1.74997016 |
| 184 | Neuroepithelial neoplasm (HP:0030063) | 1.74997016 |
| 185 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.74922767 |
| 186 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.73354756 |
| 187 | Portal hypertension (HP:0001409) | 1.72913378 |
| 188 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.71752884 |
| 189 | IgA deficiency (HP:0002720) | 1.71215451 |
| 190 | Abnormality of incisor morphology (HP:0011063) | 1.70471403 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 9.68472649 |
| 2 | BRD4 | 5.76948845 |
| 3 | MAP3K12 | 5.40580022 |
| 4 | TRIM28 | 3.54250574 |
| 5 | CASK | 2.96737444 |
| 6 | CDK19 | 2.92018707 |
| 7 | TNIK | 2.78869140 |
| 8 | SRPK1 | 2.64978267 |
| 9 | EIF2AK3 | 2.63519565 |
| 10 | MAP2K7 | 2.45928313 |
| 11 | TSSK6 | 2.25061381 |
| 12 | PAK6 | 2.19004878 |
| 13 | PIK3CG | 2.09845688 |
| 14 | KSR2 | 2.02653144 |
| 15 | STK24 | 2.01510228 |
| 16 | PBK | 10.4219854 |
| 17 | AKT3 | 1.88279691 |
| 18 | STK4 | 1.82654989 |
| 19 | NTRK3 | 1.82436107 |
| 20 | SIK3 | 1.81611869 |
| 21 | KSR1 | 1.63121938 |
| 22 | MAP2K6 | 1.59424392 |
| 23 | MAP4K1 | 1.56838191 |
| 24 | NLK | 1.49255393 |
| 25 | WNK4 | 1.48198010 |
| 26 | ZAP70 | 1.47870556 |
| 27 | MARK1 | 1.44825832 |
| 28 | MAP2K4 | 1.41150769 |
| 29 | MINK1 | 1.41038454 |
| 30 | STK39 | 1.40769069 |
| 31 | MYLK | 1.34125077 |
| 32 | MAP3K4 | 1.33999288 |
| 33 | DAPK1 | 1.31568926 |
| 34 | CAMKK2 | 1.28779679 |
| 35 | STK16 | 1.25852978 |
| 36 | MUSK | 1.24481345 |
| 37 | RAF1 | 1.23145792 |
| 38 | MST4 | 1.14685333 |
| 39 | MAP3K6 | 1.12614026 |
| 40 | SYK | 1.12297414 |
| 41 | BMPR2 | 1.10943992 |
| 42 | TEC | 1.08247375 |
| 43 | PRPF4B | 1.05367223 |
| 44 | TAOK3 | 1.02387070 |
| 45 | BMPR1B | 0.96015031 |
| 46 | FES | 0.95563005 |
| 47 | SGK2 | 0.93134323 |
| 48 | MKNK2 | 0.90789349 |
| 49 | MAPK13 | 0.89946365 |
| 50 | PRKCH | 0.89137729 |
| 51 | MAPKAPK3 | 0.87002216 |
| 52 | STK38L | 0.84496496 |
| 53 | LCK | 0.83434265 |
| 54 | BCKDK | 0.82651767 |
| 55 | TLK1 | 0.82382232 |
| 56 | TNK2 | 0.81811106 |
| 57 | PAK3 | 0.81739215 |
| 58 | MAP3K9 | 0.81361898 |
| 59 | WNK1 | 0.81075227 |
| 60 | CSNK1G3 | 0.80894347 |
| 61 | PINK1 | 0.79844221 |
| 62 | CDK5 | 0.79206715 |
| 63 | MKNK1 | 0.78816391 |
| 64 | EIF2AK2 | 0.76915023 |
| 65 | NTRK2 | 0.69260956 |
| 66 | CSNK1G2 | 0.65979964 |
| 67 | GRK7 | 0.65887281 |
| 68 | SGK3 | 0.65838965 |
| 69 | ADRBK2 | 0.65534739 |
| 70 | SIK2 | 0.65446653 |
| 71 | SGK223 | 0.65184841 |
| 72 | SGK494 | 0.65184841 |
| 73 | IKBKB | 0.64662670 |
| 74 | IRAK1 | 0.64055186 |
| 75 | MAPKAPK5 | 0.63451928 |
| 76 | ACVR1B | 0.63362613 |
| 77 | GRK5 | 0.62787574 |
| 78 | NEK6 | 0.62536776 |
| 79 | VRK2 | 0.61208383 |
| 80 | PRKCG | 0.59880940 |
| 81 | TGFBR1 | 0.58603846 |
| 82 | PIM1 | 0.57000321 |
| 83 | MOS | 0.55796981 |
| 84 | CAMK2A | 0.55191656 |
| 85 | CAMKK1 | 0.55172971 |
| 86 | TYK2 | 0.54587781 |
| 87 | ITK | 0.53550201 |
| 88 | PHKG1 | 0.53113617 |
| 89 | PHKG2 | 0.53113617 |
| 90 | IKBKE | 0.52916582 |
| 91 | JAK3 | 0.52554051 |
| 92 | MARK3 | 0.51884446 |
| 93 | JAK2 | 0.51878156 |
| 94 | CAMK2B | 0.51485269 |
| 95 | STK3 | 0.51093798 |
| 96 | EPHA4 | 0.50441033 |
| 97 | MAP3K11 | 0.49250468 |
| 98 | CAMK4 | 0.47891886 |
| 99 | CSNK1G1 | 0.47840946 |
| 100 | RPS6KA1 | 0.47469282 |
| 101 | TBK1 | 0.46880383 |
| 102 | DAPK3 | 0.46874177 |
| 103 | BTK | 0.46375023 |
| 104 | GSK3A | 0.45961949 |
| 105 | OXSR1 | 0.45287966 |
| 106 | CSNK1A1L | 0.45029827 |
| 107 | PLK2 | 0.43788585 |
| 108 | BRAF | 0.43631456 |
| 109 | MATK | 0.43328191 |
| 110 | CDK18 | 0.43024653 |
| 111 | CDK9 | 0.42546009 |
| 112 | CHUK | 0.42496704 |
| 113 | PRKCE | 0.41885776 |
| 114 | HCK | 0.41561031 |
| 115 | MAP3K14 | 0.40107849 |
| 116 | FYN | 0.39729695 |
| 117 | MAP3K13 | 0.39167974 |
| 118 | DAPK2 | 0.38794280 |
| 119 | RET | 0.38582013 |
| 120 | ARAF | 0.36713244 |
| 121 | CAMK1 | 0.35778706 |
| 122 | CDK15 | 0.35745122 |
| 123 | JAK1 | 0.35431211 |
| 124 | PRKAA2 | 0.35231732 |
| 125 | CDK11A | 0.34825611 |
| 126 | ADRBK1 | 0.34716927 |
| 127 | CDK8 | 0.33974118 |
| 128 | PDK1 | 0.33778918 |
| 129 | ROCK1 | 0.33746809 |
| 130 | EIF2AK1 | 0.33405884 |
| 131 | ROCK2 | 0.33319843 |
| 132 | NME1 | 0.33261547 |
| 133 | IRAK4 | 0.32722203 |
| 134 | CDK14 | 0.32282740 |
| 135 | MET | 0.31865141 |
| 136 | PRKG2 | 0.31690611 |
| 137 | KIT | 0.31532217 |
| 138 | RPS6KA5 | 0.31275930 |
| 139 | PRKCQ | 0.30064790 |
| 140 | LYN | 0.29988620 |
| 141 | CDK4 | 0.29358407 |
| 142 | CAMK2G | 0.28920970 |
| 143 | TYRO3 | 0.26812785 |
| 144 | CLK1 | 0.25151664 |
| 145 | PRKCI | 0.24857844 |
| 146 | VRK1 | 0.23169511 |
| 147 | PRKG1 | 0.21145999 |
| 148 | RPS6KB1 | 0.20710078 |
| 149 | CSNK1A1 | 0.19418767 |
| 150 | GRK6 | 0.15577975 |
| 151 | CAMK2D | 0.15357983 |
| 152 | CSK | 0.15341670 |
| 153 | MAP3K5 | 0.15146806 |
| 154 | SGK1 | 0.14613780 |
| 155 | PAK1 | 0.13884932 |
| 156 | CSF1R | 0.13264350 |
| 157 | TAOK1 | 0.11816219 |
| 158 | GRK1 | 0.10648554 |
| 159 | IRAK3 | 0.09741518 |
| 160 | CSNK2A2 | 0.08568267 |
| 161 | PRKCZ | 0.07721654 |
| 162 | PRKCB | 0.07645659 |
| 163 | FRK | 0.07175055 |
| 164 | IGF1R | 0.06999145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Asthma_Homo sapiens_hsa05310 | 4.48644595 |
| 2 | * Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.27126047 |
| 3 | * Allograft rejection_Homo sapiens_hsa05330 | 3.02338754 |
| 4 | * Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69142722 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.66109366 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.43431988 |
| 7 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.29176374 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26110321 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.24452835 |
| 10 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20119413 |
| 11 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.09700302 |
| 12 | Proteasome_Homo sapiens_hsa03050 | 1.92203102 |
| 13 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.88742804 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88038974 |
| 15 | Olfactory transduction_Homo sapiens_hsa04740 | 1.85244197 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.75258425 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74533278 |
| 18 | Morphine addiction_Homo sapiens_hsa05032 | 1.74318765 |
| 19 | Circadian entrainment_Homo sapiens_hsa04713 | 1.71408712 |
| 20 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.67722586 |
| 21 | GABAergic synapse_Homo sapiens_hsa04727 | 1.67416758 |
| 22 | Long-term potentiation_Homo sapiens_hsa04720 | 1.61429733 |
| 23 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.54714972 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.49813606 |
| 25 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.48991294 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.46735243 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.41565089 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.39734944 |
| 29 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39608804 |
| 30 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.39553633 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35403867 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.33506254 |
| 33 | Long-term depression_Homo sapiens_hsa04730 | 1.26429790 |
| 34 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26305594 |
| 35 | Basal transcription factors_Homo sapiens_hsa03022 | 1.26002138 |
| 36 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25685570 |
| 37 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.21927162 |
| 38 | * Leishmaniasis_Homo sapiens_hsa05140 | 1.21854087 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.21533199 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.21396449 |
| 41 | Taste transduction_Homo sapiens_hsa04742 | 1.17876344 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.17659006 |
| 43 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.17632595 |
| 44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.15927433 |
| 45 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15670727 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.15171693 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.11053346 |
| 48 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.10944422 |
| 49 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.10357555 |
| 50 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.06295748 |
| 51 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05861939 |
| 52 | Salivary secretion_Homo sapiens_hsa04970 | 1.00613428 |
| 53 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99173516 |
| 54 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.98527730 |
| 55 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.98129416 |
| 56 | Alzheimers disease_Homo sapiens_hsa05010 | 0.95140911 |
| 57 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.90581509 |
| 58 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.89175683 |
| 59 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.88888211 |
| 60 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.88439123 |
| 61 | Malaria_Homo sapiens_hsa05144 | 0.88355669 |
| 62 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.87400166 |
| 63 | Spliceosome_Homo sapiens_hsa03040 | 0.87279525 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.86109214 |
| 65 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.84489203 |
| 66 | Platelet activation_Homo sapiens_hsa04611 | 0.84337147 |
| 67 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.82774786 |
| 68 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.81298732 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.80926499 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.78424558 |
| 71 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.78237325 |
| 72 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.78018357 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.77349813 |
| 74 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.76116261 |
| 75 | Renin secretion_Homo sapiens_hsa04924 | 0.74444133 |
| 76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.73818392 |
| 77 | * Measles_Homo sapiens_hsa05162 | 0.73743574 |
| 78 | Pertussis_Homo sapiens_hsa05133 | 0.73390406 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.71104820 |
| 80 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70907509 |
| 81 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.69035105 |
| 82 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67682741 |
| 83 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.67529368 |
| 84 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.67438860 |
| 85 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66559195 |
| 86 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65988012 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.64946228 |
| 88 | Ribosome_Homo sapiens_hsa03010 | 0.64299450 |
| 89 | Huntingtons disease_Homo sapiens_hsa05016 | 0.62897293 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.61869887 |
| 91 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.61540409 |
| 92 | Peroxisome_Homo sapiens_hsa04146 | 0.59903547 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.59801886 |
| 94 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.59216361 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.59102764 |
| 96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58945750 |
| 97 | Mineral absorption_Homo sapiens_hsa04978 | 0.58742877 |
| 98 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58684215 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.56297544 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | 0.56162341 |
| 101 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55983340 |
| 102 | Gap junction_Homo sapiens_hsa04540 | 0.55040265 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.54092494 |
| 104 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.53938665 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53933548 |
| 106 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.52920102 |
| 107 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52869048 |
| 108 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.51981097 |
| 109 | Salmonella infection_Homo sapiens_hsa05132 | 0.50766308 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.48223897 |
| 111 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.48019454 |
| 112 | Shigellosis_Homo sapiens_hsa05131 | 0.47823173 |
| 113 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46213503 |
| 114 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.46110408 |
| 115 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.46096611 |
| 116 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.46094126 |
| 117 | RNA polymerase_Homo sapiens_hsa03020 | 0.44401418 |
| 118 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.43787100 |
| 119 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43660765 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.41173975 |
| 121 | Axon guidance_Homo sapiens_hsa04360 | 0.40873570 |
| 122 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.40726444 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | 0.40655160 |
| 124 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40416061 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.40256566 |
| 126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40098841 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.40088196 |
| 128 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.39936848 |
| 129 | Legionellosis_Homo sapiens_hsa05134 | 0.38067185 |
| 130 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.36868696 |
| 131 | Alcoholism_Homo sapiens_hsa05034 | 0.36536963 |
| 132 | Cell cycle_Homo sapiens_hsa04110 | 0.35974466 |
| 133 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.35707181 |
| 134 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.35503184 |
| 135 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.34759862 |
| 136 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34453170 |
| 137 | Apoptosis_Homo sapiens_hsa04210 | 0.34383026 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.33908631 |
| 139 | Purine metabolism_Homo sapiens_hsa00230 | 0.33077596 |
| 140 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32635377 |
| 141 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.32542231 |
| 142 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31588255 |
| 143 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.31397350 |
| 144 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.30021915 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.26226203 |
| 146 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.25983484 |
| 147 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.24475521 |
| 148 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.23926921 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23773842 |
| 150 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.22622078 |
| 151 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.22597503 |
| 152 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.20049351 |
| 153 | Hepatitis B_Homo sapiens_hsa05161 | 0.19864007 |
| 154 | Influenza A_Homo sapiens_hsa05164 | 0.19272103 |
| 155 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.18954064 |
| 156 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.17544155 |
| 157 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.17406893 |
| 158 | Viral myocarditis_Homo sapiens_hsa05416 | 0.17277893 |
| 159 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.16439341 |
| 160 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.12623374 |
| 161 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09851235 |
| 162 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.09483269 |
| 163 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.07554113 |
| 164 | Insulin resistance_Homo sapiens_hsa04931 | 0.06667522 |
| 165 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.05385653 |

